Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of NH600001 emulsion injection for induction of general anesthesia in elective surgery
ChiCTR2500102769Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- May 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of NH600001 and etomidate in general anesthesia (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Success rate of anesthesia induction. Planned start May 2025; status: not yet recruiting.
02
Drugs
NH600001etomidate
03
Conditions
general anesthesia
Beyond the preview
Go deeper on ChiCTR2500102769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102769.